EA
DXCM icon

Emerald Advisers’s DexCom DXCM Stock Holding History

Emerald Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,107
Closed -$261K – 250
2023
Q4 		$261K Sell
2,107
-28
-1% -$2.86K 0.01% 208
2023
Q3 		$199K Sell
2,135
-46
-2% -$5.18K 0.01% 206
2023
Q2 		$280K Sell
2,181
-31
-1% -$3.75K 0.01% 198
2023
Q1 		$257K Sell
2,212
-2,452
-53% -$274K 0.01% 201
2022
Q4 		$528K Sell
4,664
-79
-2% -$8.67K 0.03% 164
2022
Q3 		$382K Sell
4,743
-37
-0.8% -$3.13K 0.02% 188
2022
Q2 		$356K Hold
4,780
– – 0.02% 190
2022
Q1 		$611K Sell
4,780
-92
-2% -$10.1K 0.02% 179
2021
Q4 		$654K Sell
4,872
-2,876
-37% -$413K 0.02% 180
2021
Q3 		$1.06M Buy
7,748
+1,800
+30% +$227K 0.04% 151
2021
Q2 		$635K Buy
+5,948
New +$571K 0.02% 181

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Emerald Advisers's DXCM Position: Q1 2024 in Review

Emerald Advisers sold out of DexCom (DXCM) in Q1 2024, closing a stake of 2,107 shares — an estimated $261K sold.

Emerald Advisers first reported a position in DXCM in Q2 2021 and held it in 11 quarters. The position peaked at $1.06M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Emerald Advisers reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Emerald Advisers sold 2,107 DexCom shares in Q1 2024, an estimated $261K.
  • Emerald Advisers first reported a position in DexCom in Q2 2021 and held it in 11 quarters.
  • Emerald Advisers's DexCom position peaked at $1.06M in Q3 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.